Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 25, 2019
HALIX has announced the opening of its new 6,700 m² cGMP facility at the Leiden Bio Science Park.
read more
Wednesday, April 15, 2020
HALIX has joined a consortium of partners to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine being developed by the University’s Jenner Institute.
read more
HALIX announced they have met their major milestone with the interim delivery of their new 6,700 m2 cGMP facility in Leiden Bio Science Park.
read more
Wednesday, December 23, 2020
HALIX has signed an agreement with AstraZeneca for large-scale commercial drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine.
read more
Halo Pharmaceutical, a rapidly growing Contract Development and Manufacturing Organization (CDMO) is very pleased to announce the appointment of Roberto Darienzo to the newly created position of Chief Operating Officer.
read more
Wednesday, April 13, 2022
Halozyme Therapeutics, Inc. and Antares Pharma, Inc. have entered into a definitive agreement pursuant to which Halozyme will acquire Antares for $5.60 per share in cash. The transaction, which values Antares at approximately $960 million, was ...
read more
Norwich focuses on manufacturing potent, solid dose products, including fast dissolve and controlled release tablets, while also providing a range of analytical services in-house.
read more
Hangzhou Just Biotherapeutics held the grand opening ceremony for its R&D Center and Manufacturing Facility.
read more
Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services through its Contract Research Services (CRS) business, and Fluofarma, a contract research organization specializing in high content analysis, have ...
read more
Guadalupe, Nuevo Leon, Harmonic Nature is voluntarily recalling all 800 bottles Hand Sanitizer, 250mL, product due to the potential presence of 1-propanol.
read more
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more
Tuesday, December 21, 2021
Heat Biologics, Inc. a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, has executed a definitive merger agreement to acquire Elusys Therapeutics, a commercial-stage biodefense ...
read more
Heat Biologics, Inc. is changing the name of the company to NightHawk Biosciences, Inc., effective May 3, 2022, to better reflect the Company’s evolution, including expansion of its therapeutic pipeline, the vertical integration of capabilities from ...
read more
Heat Biologics, Inc. has unveiled enhanced allogeneic cell therapy manufacturing capabilities through its Scorpion Biological Services subsidiary.
read more
Heidelberg has signed a Master Service Agreement with ProBioGen for the antibodies used in two of their pipeline ATAC molecules.
read more